IGC Pharma (IGC) Total Non-Current Liabilities (2011 - 2026)
IGC Pharma (IGC) recorded Total Non-Current Liabilities of $191,000 in Q4 2026, up 19.4% from $160,000 a year earlier and up 43.6% from the prior quarter.
Powered by 
Analysis
IGC Pharma (IGC) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends
Starting with Q4 2011, IGC Pharma's Total Non-Current Liabilities history includes 60 quarters.
- Annual Total Non-Current Liabilities has a five-year compound annual growth rate of -22.8% (FY2021 to FY2026).
- Across earlier years, Total Non-Current Liabilities came in at $160,000 in FY2025 (-33.6%), $241,000 in FY2024 (-34.7%), $369,000 in FY2023 (-26.3%) and $501,000 in FY2022 (-28.0%).
- The Q4 2026 figure is the highest quarterly Total Non-Current Liabilities since Q1 2025.
- On a year-over-year basis, Total Non-Current Liabilities rose in 1 of the last eight quarters, with an average decline of 26.1%.
- Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 19.4% in Q4 2026, against a decline of 46.7% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $133,000 (Q3 2026), $137,000 (Q2 2026) and $140,000 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 97.04 Bn |
| 10 | IGC Pharma | 24.10 Mn | 21.34 Mn | 55,000.00 | 191,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 191,000.00 |
| Dec 31, 2025 | 133,000.00 |
| Sep 30, 2025 | 137,000.00 |
| Jun 30, 2025 | 140,000.00 |
| Mar 31, 2025 | 160,000.00 |
| Dec 31, 2024 | 162,000.00 |
| Sep 30, 2024 | 190,000.00 |
| Jun 30, 2024 | 225,000.00 |
| Mar 31, 2024 | 241,000.00 |
| Dec 31, 2023 | 270,000.00 |
| Sep 30, 2023 | 302,000.00 |
| Jun 30, 2023 | 340,000.00 |
| Mar 31, 2023 | 369,000.00 |
| Dec 31, 2022 | 397,000.00 |
| Sep 30, 2022 | 432,000.00 |
| Jun 30, 2022 | 467,000.00 |
| Mar 31, 2022 | 501,000.00 |
| Dec 31, 2021 | 534,000.00 |
| Sep 30, 2021 | 565,000.00 |
| Jun 30, 2021 | 595,000.00 |
API Access
IGC Pharma Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=IGC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "IGC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=IGC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();